Prefilled Syringes Market to Hit $22.8 Billion by 2029, Driven by Innovation and Demand Surge [Yahoo! Finance]
Design Therapeutics, Inc. (DSGN)
Company Research
Source: Yahoo! Finance
BOSTON June 4, 2024 /PRNewswire/ -- Prefilled syringes are medical devices that come with a pre-measured dose of medication already inside. They are designed to be used once and then disposed of, offering a convenient and safer alternative to the traditional method of drawing medicine from a vial into a syringe. "According to the latest research study, the demand for Prefilled Syringes: Global Markets expected to grow from $14.5 billion in 2024 and will reach $22.8 billion by the end of 2029 at a compound annual growth rate (CAGR) of 9.5% from 2024 through 2029" The report on prefilled syringes provides a detailed analysis of the market trends, including data from 2023, estimates for 2024, and projections through 2029. It examines the market's current and future potential, competitive landscape, regulatory factors, and key drivers and challenges. The report covers different materials (glass and polymer), types (conventional and safety), designs (single, dual, and customized chamb
Show less
Read more
Impact Snapshot
Event Time:
DSGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DSGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DSGN alerts
High impacting Design Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
DSGN
News
- Design Therapeutics Announces First Quarter 2024 Financial Results and Highlights Upcoming Program Milestones [Yahoo! Finance]Yahoo! Finance
- Design Therapeutics Announces First Quarter 2024 Financial Results and Highlights Upcoming Program MilestonesGlobeNewswire
- Design Therapeutics, Inc. (NASDAQ: DSGN) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $12.00 price target on the stock, up previously from $6.00.MarketBeat
- Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare ConferenceGlobeNewswire
DSGN
Earnings
- 3/19/24 - Beat
DSGN
Sec Filings
- 6/17/24 - Form 4
- 6/17/24 - Form 4
- 6/17/24 - Form 4
- DSGN's page on the SEC website